|
PGI-I (last visit)
|
n (%)
|
Mean IPSS change (SD)
|
Mean IPSS-QoL change (SD)
|
Mean BII change (SD)
|
Mean Qmax change (SD)
|
|---|
|
Very Much Better
|
99 (6.1%)
|
−14.4 (5.9)
|
−2.6 (1.6)
|
−5.2 (3.1)
|
3.7 (4.9)
|
|
Much Better
|
443 (27.2%)
|
−10.9 (5.6)
|
−2.0 (1.3)
|
−4.0 (2.9)
|
4.0 (5.6)
|
|
A Little Better
|
632 (38.8%)
|
−7.0 (5.4)
|
−1.0 (1.2)
|
−2.3 (2.7)
|
3.0 (5.0)
|
|
No Change
|
357 (21.9%)
|
−3.3 (5.2)
|
−0.3 (1.1)
|
−0.9 (2.7)
|
2.1 (4.3)
|
|
A Little Worse
|
65 (4.0%)
|
−0.2 (5.7)
|
0.0 (1.2)
|
−0.1 (3.0)
|
2.0 (4.8)
|
|
Much Worse
|
26 (1.6%)
|
3.5 (5.4)
|
0.5 (1.1)
|
1.8 (2.6)
|
1.3 (3.1)
|
|
Very Much Worse
|
6 (0.4%)
|
6.8 (5.1)
|
1.0 (0.9)
|
4.5 (2.1)
|
0.1 (2.0)
|
|
Overall comparison p-value
| |
<0.001
|
<0.001
|
<0.001
|
<0.001
|
|
Pairwise comparison p-value
| | | | | |
|
Better vs. No change
| |
<0.001
|
<0.001
|
<0.001
|
<0.001
|
|
Better vs. Worse
| |
<0.001
|
<0.001
|
<0.001
|
0.002
|
|
No change vs. Worse
| |
<0.001
|
<0.001
|
<0.001
|
0.534
|
|
Spearman’s Correlation
| |
0.56**
|
0.53**
|
0.47**
|
−0.15**
|
- PGI-I: Patient Global Impression of Improvement; IPSS: International Prostate Symptom Scores; IPSS QoL: IPSS-Quality of Life (QoL), BII - Benign Prostatic Hyperplasia Impact Index; Qmax: peak urine flow rate; n: number of patients; SD: Standard Deviation. Overall and pairwise comparison p-values are from analysis of variance without adjusting for covariates. **: p<0.001.
